Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TEPEZZA® safely and effectively. See full prescribing information for TEPEZZA. TEPEZZA (teprotumumab-trbw) for injection, for intravenous use Initial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
TEPEZZA is indicated for the treatment of Thyroid Eye Disease regardless of Thyroid Eye Disease activity or duration.
- generic_name
- teprotumumab
- product_names
- teprotumumab
- ndc
- 75987-130, 75987-130-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en